Insider Shareholders with Direct Ownership of Ambrx Biopharma Inc. (AMAM)
This section provides a comprehensive overview of the insiders with direct ownership of Ambrx Biopharma Inc. (AMAM). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Ambrx Biopharma Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Daniel J. O'Connor
President and CEO |
2,750,000 | 0 | 2,750,000 $77 Million | 1 |
Apr 26, 2023
Added 50.0%
|
|
Sonja Nelson
Chief Financial Officer |
1,000,000 | 0 | 1,000,000 $28 Million | 1 |
Apr 26, 2023
Added 50.0%
|
|
Paul V Maier
Director |
85,000 | 0 | 85,000 $2.38 Million | 1 |
Jun 07, 2023
Added 50.0%
|
|
Steve C Glover
Director |
85,000 | 0 | 85,000 $2.38 Million | 1 |
Jun 07, 2023
Added 50.0%
|
|
Janet Loesberg
Director |
85,000 | 0 | 85,000 $2.38 Million | 1 |
Jun 07, 2023
Added 50.0%
|
|
Kate Hermans
Director |
85,000 | 0 | 85,000 $2.38 Million | 1 |
Jun 07, 2023
Added 50.0%
|
| 195,833 | 0 | 70,833 $1.98 Million | 1 |
Sep 01, 2023
Added 50.0%
|